Dental surgery in anticoagulated patients

Area of Science:

• Oral anticoagulation therapy
• Thromboembolism prevention
• Dental surgery management

Background:

• Continuous oral anticoagulant therapy, like warfarin, has been a mainstay for over 50 years to prevent thromboembolism.
• Physicians often recommend interrupting anticoagulant therapy for dental procedures to mitigate bleeding risks.

Purpose of the Study:

• To evaluate the risks and benefits of continuing versus interrupting oral anticoagulant therapy for dental surgery.
• To analyze the literature regarding bleeding complications and thromboembolic events in patients undergoing dental procedures while on anticoagulation.

Main Methods:

• Literature review of documented cases concerning dental surgery in patients on continuous warfarin sodium therapy.
• Analysis of reported bleeding complications and thromboembolic events.

Main Results:

• No well-documented cases of serious bleeding from dental surgery in patients on therapeutic warfarin levels were found.
• Several documented cases of serious embolic complications occurred in patients whose warfarin was withdrawn for dental treatment.
• Dental extractions can be performed with minimal bleeding risk in patients at therapeutic anticoagulation levels.

Conclusions:

• The theoretical risk of hemorrhage after dental surgery with therapeutic anticoagulation is minimal and manageable with local measures.
• The risk of thromboembolism following the withdrawal of anticoagulant therapy for dental procedures significantly outweighs the risk of bleeding.
• Continuing therapeutic warfarin levels for dental treatment is supported by clinical evidence and legal considerations.